Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Duarte Batista L, Tucker KL, Bigornia S, Noel SE, Harris WS, Marques Braga RA, Valentini Neto J, Teixeira Damasceno NR, Macedo Rogero M, Mori Sarti F, Mattei J, Fisberg RM. Association of two cut-off points for the n-3 index with cardiometabolic risk factors in Brazilian and Puerto Rican middle-aged adults. Br J Nutr. 2025 Sep 14; 134(5):401-412.
-
Kj?rgaard J, Lindqvist CB, Quesada JP, Jessen S, Schlabs F, Ehrlich AM, Yonamine CY, Garc?a-Ure?a M, Schmalbruch JH, Small L, Thomassen M, Lemminger AK, Eibye K, Gonzalez-Franquesa A, Stidsen JV, H?jlund K, Zierath JR, Kilpel?inen TO, Bangsbo J, Treebak JT, Hostrup M, Deshmukh AS. Insulin- and exercise-induced phosphoproteomics of human skeletal muscle identify REPS1 as a regulator of muscle glucose uptake. Cell Rep Med. 2025 Jun 17; 6(6):102163.
-
Mita MM, Mita AC, Carver BJ, Shanahan JM, Mayes BA, Dufour PJ, Browning D, Anderson-Villaluz A, Petersen JS, Turnquist DJ, Cornelius P. A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2. Cancer Res Commun. 2025 Jun 01; 5(6):1008-1017.
-
Kj?rgaard J, Stocks B, Henderson J, Freemantle JB, Rizo-Roca D, Puglia M, Madrazo Montoya M, Andersson D, B?ckdahl J, Eriksson-Hogling D, Stidsen JV, Wierer M, Rasmussen S, Sakamoto K, H?jlund K, Ryd?n M, Zierath JR, Krook A, Deshmukh AS. Personalized molecular signatures of insulin resistance and type 2 diabetes. Cell. 2025 Jul 24; 188(15):4106-4122.e16.
-
Dagdeviren S, Hoang MF, Wang J, Goldberger T, Yu AM, Blair SJ, Benoit JC, Ricci-Blair EM, Melnik VY, Kim BY, Tauer LA, Scholz JJ, Worthmann A, Schlein C, Stone D, Deuitch NT, Aksentijevich I, Schnappauf O, Whited JL, Kim JK, Lee RT. Covalent binding of thioredoxin to TXNIP is required for diet-induced insulin resistance in the liver. J Biol Chem. 2025 Jun; 301(6):110214.
-
Rizo-Roca D, Henderson JD, Zierath JR. Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes. J Intern Med. 2025 Jun; 297(6):584-607.
-
Martinez Bravo G, Paramasivam P, Bellissimo GF, Jacquez Q, Zheng H, Amorim F, Kovell L, Alvidrez RIM. High-Intensity Interval Training Decreases Circulating HMGB1 in Individuals with Insulin Resistance: Plasma Lipidomics Correlate with Associated Cardiometabolic Benefits. Front Biosci (Landmark Ed). 2025 Mar 21; 30(3):31396.
-
Ashcroft SP, Ehrlich AM, Burek K, Pendergrast LA, Yonamine CY, Treebak JT, Zierath JR. Enhanced metabolic adaptations following late dark phase wheel running in high-fat diet-fed mice. Mol Metab. 2025 May; 95:102116.
-
Pittala S, Haspula D, Cui Y, Yang WM, Kim YB, Davis RJ, Wing A, Rotman Y, McGuinness OP, Inoue A, Wess J. G12/13-mediated signaling stimulates hepatic glucose production and has a major impact on whole body glucose homeostasis. Nat Commun. 2024 11 19; 15(1):9996.
-
Yuzefovych LV, Noh HL, Suk S, Schuler AM, Mulekar MS, Pastukh VM, Kim JK, Rachek LI. Mitochondria-Targeted DNA Repair Glycosylase hOGG1 Protects Against HFD-Induced Liver Oxidative Mitochondrial DNA Damage and Insulin Resistance in OGG1-Deficient Mice. Int J Mol Sci. 2024 Nov 13; 25(22).